
Tumor-secreted exosomes play a significant role in cancer cell growth, metastasis, and drug resistance. Klotho beta (KLB), upregulated in prostate cancer, is linked to malignancy. KLB overexpression hinders exosome release, causing multivesicular body accumulation, likely through a Rab8a-dependent route. Modulating Rab8a rescues exosome release and counters KLB-induced malignancy. These insights suggest KLB's tumor-promoting role through exosome regulation, holding potential for novel prostate cancer treatments.
Like
Save
Share